Clinical Trial Update: Tretinoin and Arsenic Trioxide With or Without Idarubicin in Treating Patients With Acute Promyelocytic Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating tretinoin and arsenic trioxide with or without idarubicin for acute promyelocytic leukemia was terminated, and results were posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Promyelocytic Leukemia
• Leukemia

Drugs mentioned

• Idamycin (idarubicin)
• Trisenox (arsenic trioxide)
• Vesanoid (all-trans retinoic acid)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2016-01-29